From: The role of oncostatin M receptor gene polymorphisms in bladder cancer
Characteristics | Cases No. | Genotype No. (%) | P value | Allele No. (%) | P value | OR (95%CI) | |||
---|---|---|---|---|---|---|---|---|---|
GG | GT | TT | G | T | |||||
Gender | |||||||||
 Male | 241 (78.8) | 104 (43.1) | 108 (44.8) | 29 (12.0) | 0.43 | 316 (65.6) | 166 (34.4) | 0.34 | 1.23 (0.81–1.87) |
 Female | 65 (21.2) | 32 (49.2) | 27 (41.5) | 6 (9.2) | 91 (70.0) | 39 (30.0) | |||
Age | |||||||||
 ≤ 64 | 139 (45.4) | 61 (43.9) | 63 (45.3) | 15 (10.8) | 0.65 | 185 (66.5) | 93 (33.5) | 0.98 | 0.99 (0.71–1.40) |
 > 64 | 167 (54.6) | 75 (44.9) | 72 (43.1) | 20 (12.0) | 222 (66.5) | 112 (33.5) | |||
Smoking status | |||||||||
 Non-smokers | 147 (48.0) | 65 (44.2) | 62 (42.2) | 20 (13.6) | 0.35 | 192 (65.3) | 102 (34.7) | 0.55 | 1.11 (0.79–1.55) |
 Smokers | 159 (52.0) | 71 (44.6) | 73 (45.9) | 15 (9.4) | 215 (67.6) | 103 (32.4) | |||
Stage | |||||||||
 NMIBC | 164 (53.6) | 75 (45.7) | 69 (42.1) | 20 (12.2) | 0.72 | 219 (66.8) | 109 (33.2) | 0.88 | 0.98 (0.70–1.37) |
 MIBC | 142 (46.4) | 61 (43.0) | 66 (46.5) | 15 (10.6) | 188 (66.2) | 96 (33.8) | |||
Grade | |||||||||
 Low | 132 (43.1) | 65 (49.2) | 47 (35.6) | 20 (15.2) | 0.009 | 177 (67.0) | 87 (33.0) | 0.81 | 0.96 (0.68–1.35) |
 High | 174 (56.9) | 71 (40.8) | 88 (50.6) | 15 (8.6) | 230 (66.1) | 118 (33.9) | |||
Recurrence | |||||||||
 Negative | 217 (70.9) | 106 (48.9) | 88 (40.5) | 23 (10.6) | 0.036 | 300 (69.1) | 134 (30.9) | 0.032 | 0.67 (0.47–0.97) |
 Positive | 89 (29.1) | 30 (33.7) | 47 (52.8) | 12 (13.5) | 107 (60.1) | 71 (39.9) |